• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Introduction to 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine (CAS No. 64278-19-9)

1,1-dimethyl-2,3-dihydro-1H-inden-5-amine, identified by its Chemical Abstracts Service (CAS) number 64278-19-9, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indene class, characterized by a fused benzene and cyclopentane ring system, and it is distinguished by the presence of two methyl groups at the 1-position and an amine substituent at the 5-position. The structural features of 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine make it a versatile scaffold for the development of novel bioactive molecules.

The synthesis of 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine typically involves multi-step organic transformations, often starting from readily available precursors such as indene or its derivatives. The introduction of the dimethyl group at the 1-position enhances the lipophilicity of the molecule, which can be crucial for its interaction with biological targets. Additionally, the amine functionality provides a site for further chemical modification, allowing for the exploration of various pharmacophores. Advanced synthetic methodologies, including catalytic hydrogenation and nucleophilic substitution reactions, have been employed to achieve high yields and purity in its preparation.

In recent years, 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine has been investigated for its potential biological activities. Its indene core is known to exhibit structural similarity to several natural products and pharmacologically active compounds, suggesting that it may possess therapeutic properties. Preliminary studies have explored its interactions with enzymes and receptors relevant to neurological disorders, inflammation, and cancer. The amine group in particular has been highlighted as a key moiety for modulating binding affinity and selectivity.

One of the most compelling areas of research involving 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine is its application in drug discovery programs targeting central nervous system (CNS) disorders. The compound’s ability to cross the blood-brain barrier has been a focus of interest due to its potential as a neuroactive agent. Researchers have synthesized derivatives of this scaffold to optimize pharmacokinetic properties while maintaining biological activity. These derivatives have shown promise in preclinical models for conditions such as depression and neurodegeneration.

The pharmacological profile of 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine has been further elucidated through computational modeling and experimental assays. Molecular docking studies have identified potential binding pockets on target proteins where this compound could exert its effects. Additionally, in vitro tests have revealed interesting interactions with enzymes such as monoamine oxidases (MAOs) and cyclooxygenases (COX), which are implicated in various disease pathways. These findings provide a strong rationale for exploring 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine as a lead compound or intermediate in medicinal chemistry campaigns.

Recent advances in biocatalysis have also opened new avenues for the functionalization of 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine. Enzymatic approaches offer a sustainable and efficient alternative to traditional synthetic methods, particularly for introducing complex functional groups with high precision. For instance, transaminase-catalyzed reactions have been employed to install amine functionalities at specific positions on the indene backbone. Such biocatalytic strategies align with green chemistry principles and could enhance the scalability of producing this compound for research purposes.

The role of 1,1-dimethyl-2,3-dihydro-1H-inden-5-amine in medicinal chemistry extends beyond CNS disorders. Its structural motif has been incorporated into libraries designed for screening against other diseases such as cardiovascular conditions and metabolic syndromes. The compound’s ability to modulate key signaling pathways has made it an attractive candidate for further optimization by medicinal chemists. By leveraging structure-based design principles and combinatorial chemistry techniques, researchers aim to develop analogs with improved efficacy and reduced toxicity.

In conclusion, 64278_19_9 represents a promising scaffold with significant potential in drug development. Its unique structural features combined with versatile synthetic accessibility make it an invaluable asset for medicinal chemists exploring novel therapeutic agents. As research continues to uncover new biological activities and synthetic methodologies, 64278_19_9 is poised to play an important role in addressing unmet medical needs across multiple therapeutic areas.

• 917805-33-5(1H-Indene-4,7-diamine, 2,3-dihydro-1,1,3-trimethyl-)
• 852448-09-0(Benzenamine, 4-[(2,3-dihydro-1H-inden-1-yl)methyl]-)
• 92050-16-3(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine)
• 54628-89-6(1H-Inden-5-amine,1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-)
• 54628-90-9(3-(4-aminophenyl)-1,1,3-trimethyl-2,3-dihydro-1H-inden-5-amine)
• 50593-97-0(1,1,3,3-tetramethyl-2,3-dihydro-1H-inden-5-amine)
• 39095-77-7(Spiro[cyclopropane-1,1'-[1H]inden]-5'-amine, 2',3'-dihydro-)
• 88297-77-2(1H-Inden-4-amine, 2,3-dihydro-1,1-dimethyl-)
• 113505-06-9(4-[1-(4-aminophenyl)-2,3-dihydroinden-1-yl]aniline)
• 93369-00-7(Benzenamine, 4-(2,3-dihydro-1,3,3-trimethyl-1H-inden-1-yl)-)